Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.

Shan-Shan YangYa-Jun PangZhi-Qiang WangBao-Yu ZhangZhi-Qiao LiuEn-Ni ChenPu-Yun OuYangFang-Yun Xie

Published in: Cancer medicine (2021)

A risk score model was developed and prospectively validated to precisely select high-risk stage II NPC patients who can benefit from CCRT, and thus guided individualized treatment in IMRT era.

Keyphrases

locally advanced
rectal cancer
early stage
radiation therapy
squamous cell carcinoma
radiation induced
replacement therapy